These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 364249)

  • 21. Effects of insulin and NSILA on adipocytes of normal and diabetic rats: receptor binding, glucose transport and glucose metabolism.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1977 May; 13(3):243-9. PubMed ID: 141388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat.
    Poffenbarger PL; Haberal MA
    Surgery; 1976 Nov; 80(5):608-16. PubMed ID: 982280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of partially purified preparations with nonsuppressible insulin-like activity (NSILA-S) on sulfate incorporation into rat and chicken cartilage.
    Zingg AE; Froesch ER
    Diabetologia; 1973 Dec; 9(6):472-6. PubMed ID: 4773548
    [No Abstract]   [Full Text] [Related]  

  • 25. Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1979 Jan; 16(1):41-6. PubMed ID: 761737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the binding of multiplication-stimulating activity to a receptor for growth polypeptides in chick embryo fibroblasts.
    Rechler MM; Podskalny JM; Nissley SP
    J Biol Chem; 1977 Jun; 252(11):3898-910. PubMed ID: 558977
    [No Abstract]   [Full Text] [Related]  

  • 28. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsuppressible insulin-like activity: biological activity and receptor binding.
    Zapf J; Mäder M; Waldvogel M; Froesch ER
    Isr J Med Sci; 1975 Jul; 11(7):664-78. PubMed ID: 169212
    [No Abstract]   [Full Text] [Related]  

  • 30. Binding of nonsuppressible insulin-like activity (NSILA) to isolated fat cells: evidence for two separate membrane acceptor sites.
    Schoenle E; Zapf J; Froesch ER
    FEBS Lett; 1976 Aug; 67(2):175-9. PubMed ID: 182551
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonsuppressible insulin-like activity (NSILA) of human serum. V. Hypoglycaemia and preferential metabolic stimulation of muscle by NSILA-S.
    Oelz O; Jakob A; Froesch ER
    Eur J Clin Invest; 1970 Mar; 1(1):48-53. PubMed ID: 5470477
    [No Abstract]   [Full Text] [Related]  

  • 32. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)].
    Binoux M; Lassarre C; Seurin D
    Ann Endocrinol (Paris); 1980; 41(1):67-9. PubMed ID: 7396401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsuppressible insulinlike activity (NSILA) and the glucose dyshomeostasis of agonal sepsis.
    Viray RE; Filkins JP
    Adv Shock Res; 1983; 9():31-41. PubMed ID: 6349307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey.
    Blumenthal S
    Perspect Biol Med; 2010; 53(4):491-508. PubMed ID: 21037404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Somatomedins (author's transl)].
    Binoux M
    Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance and metabolic action of insulin and nonsuppressible insulin-like activity (NSILA) in the isolated perfused rat heart.
    Solomon SS; Challoner DR; Ensinck JW; Williams RH
    Diabetes; 1967 Aug; 16(8):545-50. PubMed ID: 6041182
    [No Abstract]   [Full Text] [Related]  

  • 37. Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S).
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):127-36. PubMed ID: 6772355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of insulin and of NSILA-S on the perfused rat heart: glucose uptake, lactate production and efflux of 3-0-methyl glucose.
    Meuli C
    Eur J Clin Invest; 1975 Feb; 5(1):93-9. PubMed ID: 1122929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)].
    Froesch ER; Zapf J
    Ann Endocrinol (Paris); 1980; 41(6):502-11. PubMed ID: 7018376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.